I now have sufficient data from multiple authoritative textbooks. Let me compile the comprehensive USMLE-oriented epilepsy decision tree.
Epilepsy: USMLE Decision Tree
STEP 1 — Is It a Seizure? Rule Out Mimics
| Feature | Seizure | Syncope | Psychogenic (PNES) |
|---|
| Aura | May have (rising epigastric, déjà vu) | Light-headedness, graying | Variable, prolonged |
| Onset | Sudden or with aura | Situational (standing, pain) | Gradual, emotional trigger |
| Duration | Usually <3 min | Seconds | Often >2 min |
| Postictal confusion | Yes | No (rapid recovery) | Variable |
| Tongue bite | Lateral | Tip only | Rare |
| Todd's paralysis | Focal paresis post-ictally = focal onset | No | No |
| EEG | Epileptiform activity | Normal | Normal (during event) |
STEP 2 — ILAE 2017 Seizure Classification
SEIZURE
│
├── FOCAL ONSET (single hemisphere)
│ ├── Focal Aware (old: Simple Partial)
│ │ └── consciousness preserved
│ ├── Focal Impaired Awareness (old: Complex Partial)
│ │ └── impaired consciousness + automatisms
│ └── Focal → Bilateral Tonic-Clonic (old: Secondary Generalization)
│
├── GENERALIZED ONSET (both hemispheres simultaneously)
│ ├── Motor
│ │ ├── Tonic-Clonic (Grand Mal) — loss of consciousness, tonic then clonic, postictal state
│ │ ├── Myoclonic — brief, sudden jerks (<100 ms), no postictal state
│ │ ├── Tonic — sustained muscle stiffening
│ │ ├── Clonic — rhythmic jerking
│ │ └── Atonic (Drop Attack) — sudden loss of tone → falls
│ └── Non-Motor
│ ├── Typical Absence (Petit Mal)
│ │ └── 4–20 sec stare, abrupt onset/offset, NO postictal state
│ └── Atypical Absence — longer, less abrupt (Lennox-Gastaut)
│
└── EPILEPTIC SPASMS — West syndrome (infantile)
Katzung's Basic and Clinical Pharmacology, 16th Ed. — Table 24-1; Adams and Victor's Principles of Neurology, 12th Ed.
STEP 3 — Identify the Epilepsy Syndrome
| Syndrome | Age of Onset | Seizure Type(s) | EEG | Key Pearl |
|---|
| Childhood Absence Epilepsy (CAE) | 4–10 y (peak 5–7) | Typical absence | 3 Hz spike-wave | Mostly remits by age 12 |
| Juvenile Absence Epilepsy | Adolescence | Absence + GTC | 3–4 Hz spike-wave | Persists into adulthood |
| Juvenile Myoclonic Epilepsy (JME) | 12–18 y | Myoclonic jerks (AM) + GTC ± absence | 4–6 Hz polyspike-wave | Lifelong; triggered by sleep deprivation |
| Benign Epilepsy with Centrotemporal Spikes (BECTS/Rolandic) | 3–13 y | Focal (face/arm) nocturnal | Centrotemporal spikes | Remits by puberty |
| Temporal Lobe Epilepsy | Any age | Focal impaired awareness + automatisms | Temporal slowing | Most common adult focal epilepsy; Todd's paralysis = focal onset |
| West Syndrome | < 1 y | Epileptic spasms | Hypsarrhythmia | Triad: spasms + hypsarrhythmia + developmental regression |
| Lennox-Gastaut Syndrome | 1–7 y | Multiple types (tonic, atonic, atypical absence) | Slow (<2.5 Hz) spike-wave | Refractory; drop attacks → helmet needed |
| Dravet Syndrome | <1 y | Febrile then afebrile, myoclonic | Polyspike | SCN1A mutation; avoid Na-channel blockers (lamotrigine, carbamazepine) |
STEP 4 — Drug of Choice by Seizure / Syndrome
SEIZURE TYPE
│
├── FOCAL (any type) ─────────────────────────────────────────────────
│ First-line: Levetiracetam, Lamotrigine, Oxcarbazepine
│ Alternatives: Carbamazepine, Phenytoin, Lacosamide, Zonisamide
│ Note: Lamotrigine needs slow titration; Levetiracetam/Oxcarbazepine
│ can be started at effective dose quickly
│
├── GENERALIZED TONIC-CLONIC (Primary/IGE) ──────────────────────────
│ First-line: Valproate*, Levetiracetam, Lamotrigine
│ (*Valproate: avoid in women of childbearing age — teratogen)
│
├── TYPICAL ABSENCE ──────────────────────────────────────────────────
│ First-line: Ethosuximide (best efficacy + tolerability)
│ If also has GTC: Valproate (covers both)
│ Alternative: Lamotrigine
│ ⚠ AVOID: Carbamazepine, Phenytoin (worsen absence!)
│
├── MYOCLONIC (JME) ──────────────────────────────────────────────────
│ First-line: Valproate, Levetiracetam
│ Alternative: Lamotrigine, Topiramate
│ ⚠ AVOID: Carbamazepine (worsens myoclonus!)
│
├── ATONIC / LENNOX-GASTAUT ──────────────────────────────────────────
│ Valproate, Lamotrigine + Valproate (synergistic), Rufinamide,
│ Clobazam, Topiramate, Felbamate
│
├── INFANTILE SPASMS (West Syndrome) ────────────────────────────────
│ First-line: ACTH or Vigabatrin (TSC: Vigabatrin preferred)
│ Alternative: Prednisolone, Pyridoxine (if B6 deficiency)
│
└── DRAVET SYNDROME ──────────────────────────────────────────────────
Valproate, Clobazam, Stiripentol, Cannabidiol (Epidiolex)
⚠ AVOID: Lamotrigine, Carbamazepine (Na-channel blockers → worse)
Bradley and Daroff's Neurology in Clinical Practice — "Initiating Therapy"; Katzung's 16th Ed.; Adams and Victor's Principles of Neurology
STEP 5 — Pharmacoresistant Epilepsy
- Defined as failure of ≥2 appropriate AEDs at adequate doses
- Refer for epilepsy surgery evaluation
- Temporal lobectomy: best outcomes for mesial temporal lobe epilepsy
- Lesionectomy: for tumors, vascular malformations, cortical dysplasia
- Non-pharmacologic options:
- Vagus nerve stimulator (VNS) — open-loop; approved for refractory focal + LGS
- Responsive neurostimulation (RNS) — closed-loop; detects + aborts focal seizures
- Deep brain stimulation (DBS) — anterior nucleus of thalamus; focal with/without secondary generalization
- Ketogenic diet — especially effective in myoclonic epilepsies, infantile spasms, Dravet, GLUT1 deficiency (first-line for GLUT1)
Katzung's 16th Ed., p. 640
STEP 6 — Status Epilepticus (SE) Protocol
Seizure duration ≥5 min (GTC) or ≥10 min (non-convulsive) → STATUS EPILEPTICUS
PHASE 1 — Immediate (0–5 min)
• ABCs, IV access, glucose check
• Thiamine 100 mg IV (if alcoholism suspected) → then Dextrose
PHASE 2 — Benzodiazepine (5–20 min) ← FIRST-LINE
• IV lorazepam 0.1 mg/kg (preferred — longer CNS duration vs. diazepam)
• IM midazolam (if no IV access) — equally effective prehospital
• Rectal diazepam or intranasal midazolam (prehospital alternatives)
Note: Diazepam redistributes to fat rapidly → shorter CNS duration
Lorazepam has less peripheral redistribution → longer effective duration
PHASE 3 — 2nd-line (20–40 min, if benzo-refractory)
All equally effective (ESETT trial):
• Levetiracetam IV
• Valproate IV
• Fosphenytoin IV (prodrug of phenytoin; less phlebitis/arrhythmia risk)
• Phenytoin IV (slower; cardiac monitoring required)
PHASE 4 — Refractory SE (>40 min)
• Intubate
• Propofol, Midazolam infusion, or Pentobarbital
• Continuous EEG monitoring mandatory
• Phenobarbital IV (highly effective but causes prolonged sedation, respiratory depression)
ABSENCE STATUS EPILEPTICUS:
• IV benzodiazepine → IV valproate
• Long-term: oral ethosuximide or valproate
Katzung's 16th Ed. — "Status Epilepticus"; Tintinalli's Emergency Medicine
HIGH-YIELD USMLE PEARLS
| Topic | Key Fact |
|---|
| Absence vs. Complex Partial | Absence: abrupt onset/offset, no postictal state, <20 sec. Complex partial: prolonged, postictal confusion, automatisms |
| EEG for absence | 3 Hz generalized spike-and-wave — pathognomonic |
| Hyperventilation | Provokes absence seizures (used diagnostically) |
| Febrile seizures | Simple (<15 min, generalized, no recurrence in 24 h) — benign, no AED needed |
| Todd's paralysis | Transient focal weakness post-seizure → indicates focal cortical origin |
| Valproate side effects | Weight gain, hair loss, hepatotoxicity, thrombocytopenia, neural tube defects (teratogen — supplement folate) |
| Phenytoin side effects | Gingival hyperplasia, hirsutism, ataxia, nystagmus, zero-order kinetics (small dose → large [drug] increase), Stevens-Johnson syndrome |
| Carbamazepine side effects | Diplopia, ataxia, SIADH, aplastic anemia, SJS; induces CYP3A4 |
| Lamotrigine in pregnancy | Relatively safer; monitor levels (clearance increases in pregnancy) |
| Ethosuximide | Only effective for absence seizures — does NOT cover GTC |
| Drug–drug interaction | Valproate inhibits lamotrigine metabolism → halve lamotrigine dose; Carbamazepine induces its own metabolism (autoinduction) |
| JME management | Lifelong AED usually required; sleep deprivation + alcohol are triggers |
| GLUT1 deficiency | Ketogenic diet = first-line; AEDs ineffective |
| Dravet + Na-channel blockers | Lamotrigine and carbamazepine worsen Dravet — tested high-yield concept |
Sources: Katzung's Basic and Clinical Pharmacology 16th Ed. | Adams and Victor's Principles of Neurology 12th Ed. | Bradley and Daroff's Neurology in Clinical Practice | Tintinalli's Emergency Medicine | Lippincott Illustrated Reviews: Pharmacology